Developer of novel gene therapy designed to restore vision in patients. The company's therapy technology delivers a light-sensor gene specifically to cone cells that have lost light sensitivity, and r...

Healthcare
Basel, Switzerland
Founded 2024
5 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$97.9M
Last Round
N/A